Dr Reddys Laboratories RDY
NYSE RDY
$12.18 +0.07 (+0.58%)
At close: Aug 20, 2026 · 12:47 PM UTC

Dr Reddys Laboratories (RDY) Return on Assets (2009 - 2026)

Dr Reddys Laboratories (RDY) posted quarterly Return on Assets of 0.0% for Q1 2026, little changed year-over-year from 0.0% in Q1 2025, and down 56.64% quarter-over-quarter from 0.0% in Q1 2025.

Dr Reddys Laboratories (RDY) Return on Assets (2009 - 2026) Analysis & Trends

Dr Reddys Laboratories' Return on Assets history runs 3 years deep, the most recent figure standing at 0.0% for Q1 2026.

  • In Q1 2026, Return on Assets changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), while the FY2026 annual figure was 0.0%, changed 0.0% from the prior year.
  • Return on Assets for Q1 2026 stood at 0.0%, down from 0.0% in the prior quarter.
  • The five-year high for Return on Assets was 0.0% in Q1 2025, with the low at 0.0% in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Haleon 43.98 Bn 43.02 Bn - 0.00%
2 Teva Pharmaceutical Industries 43.28 Bn 39.62 Bn 2.15 Bn 0.00%
3 Zoetis 31.79 Bn 30.11 Bn 1.05 Bn 0.00%
4 Takeda Pharmaceutical 28.69 Bn 22.89 Bn 5.10 Bn 0.00%
5 United Therapeutics 22.25 Bn 19.58 Bn 683.80 Mn 0.00%
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn 0.00%
7 Neurocrine Biosciences 15.58 Bn 15.19 Bn 935.80 Mn 0.00%
8 Elanco Animal Health 11.87 Bn 11.34 Bn 798.00 Mn 0.00%
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - 0.00%
10 Alkermes 8.15 Bn 7.49 Bn 397.90 Mn 0.00%

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00%
Mar 31, 2025 0.00%
Dec 31, 2009 0.00%
Sep 30, 2009 0.00%